In a judgement delivered on 19 November, the Competition Appeal Tribunal (the “CAT”) dismissed applications by the BCL and rampian Claimants for an extension of time in which to bring follow-on claims for damages against members of a cartel in the 1990s found by the European Commission to have infringed EU Competition rules in the market for vitamins A, E and B2.